Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
Food and Drugs Act Modernization initiative, as it relates to reform of drug submission review and approval process.
Legislative Proposal, Bill or Resolution, Regulation
Food and Drugs Act and Regulations, as they relate to drug export and cross-border trade.
Food and Drugs Act and Regulations, as they relate to the establishment of an approval framework for subsequent entry biologic products.
Food and Drugs Act and Regulations, as they relate to the provision of data exclusivity for innovative drug products.
Food and Drugs Act and Regulations, as they relate to the review and approval of new drug submissions and post market surveillance of drug products.
Patent Act and Patented Medicines (Notice of Compliance) Regulations, as it relates to the regulation of intellectual property and approval for therapeutic products.
Patented Medicine Prices Review Board (PMPRB), as it relates to reporting requirements, pricing guidelines, and dispute resolution.
Policies or Program
Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Industry Canada Advantage Canada and Science and Technology Strategies, or other Government policy or program initiatives to support research and development activities in Canada.
National Pharmaceutical Strategy, as it relates to enhanced access to orphan drugs and incentives for development of the treatments for rare disorders.